Nihon Chouzai Co (3341.T) Osake Kurssi
Nihon Chouzai Co Kurssi
Viimeisten 19 vuoden aikana Nihon Chouzai Con liikevaihto kasvoi 10,0 % vuodessa ja ylsi 360,51 Mrd. JPY:een. Osakekohtainen tulos on laskenut 3,6 % vuodessa viimeisten 19 vuoden aikana. Nihon Chouzai Con nettomarginaali 0,4 % on pääosin vakaa verrattuna 1,3 %:iin muutama vuosi sitten. Nykyhinnalla osinkotuotto on noin 0,64 %. Jakosuhde on noin 54 % tuloksesta. Osinko on kasvanut 3,3 % vuodessa viimeisten 19 vuoden aikana.
Nihon Chouzai Co osakekurssi
Hae nämä tiedot Eulerpool API:n kautta
100 000 pyyntöä/kk ilmaiseksi · ei luottokorttia
Nihon Chouzai Co liiketoimintamalli ja osakeanalyysi
Usein kysytyt kysymykset Nihon Chouzai Co -osakkeesta
Nihon Chouzai Co Ltd operates as a pharmaceutical wholesaler in Japan. Nihon Chouzai is focused on providing a wide range of products and services to support the pharmaceutical industry. The company's business model revolves around sourcing and distributing pharmaceutical products to pharmacies, hospitals, and medical institutions. Nihon Chouzai aims to ensure the availability of high-quality pharmaceuticals, enhance logistical efficiency, and contribute to the overall improvement of healthcare in Japan. As a leading player in the Japanese pharmaceutical wholesale market, Nihon Chouzai's business model is centered on delivering reliable and efficient pharmaceutical supply chain solutions to meet the diverse needs of healthcare providers across the country.
Nihon Chouzai Co Ltd is primarily active in the pharmaceutical and healthcare industries.
The main competitors of Nihon Chouzai Co Ltd in the market include companies like Medipal Holdings Corporation, M3 Inc., and Medinet Co Ltd. These companies also operate in the pharmaceutical and healthcare industry, providing similar services and solutions.
Nihon Chouzai Co Ltd is a Japanese company with a rich history and background in the pharmaceutical industry. Established in 1959, Nihon Chouzai has been a key player in the distribution of pharmaceutical products throughout Japan. The company focuses on providing medicines and healthcare products to hospitals, clinics, and pharmacies, ensuring the availability of essential treatments to the Japanese population. With its extensive network and expertise in the pharmaceutical field, Nihon Chouzai has built strong relationships with various pharmaceutical manufacturers and suppliers, allowing them to consistently deliver quality products and contribute to the overall healthcare system in Japan.
Nihon Chouzai Co Ltd, a leading company in the pharmaceutical industry, has achieved several significant milestones. Over the years, the company has successfully expanded its operations, established a strong market presence, and achieved consistent revenue growth. Nihon Chouzai has also actively pursued strategic partnerships and collaborations, enabling it to enhance its product portfolio and strengthen its competitive position. Furthermore, the company has invested in research and development, leading to the introduction of innovative and high-quality pharmaceutical products. Nihon Chouzai's commitment to exceptional customer service and its strong focus on innovation has solidified its reputation as a trusted and reliable player in the pharmaceutical sector.
Nihon Chouzai Co Ltd is primarily present in Japan.
Nihon Chouzai Co Ltd represents a set of values and corporate philosophy that underpin its operations. The company focuses on promoting health and well-being by providing comprehensive pharmaceutical services and products. Nihon Chouzai Co Ltd is committed to offering high-quality healthcare solutions to its customers, ensuring their satisfaction and trust. With a strong emphasis on integrity, innovation, and professionalism, the company aims to contribute to society through its dedication to improving people's lives. Nihon Chouzai Co Ltd's corporate philosophy revolves around customer-centricity, continuous improvement, and fostering partnerships with stakeholders.
7 analyytikkoa arvioi tällä hetkellä Nihon Chouzai Co-osaketta: 0 suosittaa ostoa, 3 pitoa ja 4 myyntiä. Vuodelle 2026 analyytikot odottavat Nihon Chouzai Co-yhtiöltä 383,90 Mrd. JPY liikevaihtoa ja 143,70 JPY osakekohtaista tulosta.
Nykyisellä valuuttakurssilla Nihon Chouzai Co-osake noteerataan hintaan 22,22 EUR (3 910,00 JPY).
Nihon Chouzai Co-osake (3341.T) on listattuna 1 pörssissä, muun muassa: Tokio (JPX) (3341.T).
Nihon Chouzai Co Ltd is a company specializing in the sale of pharmaceuticals and medical products. It was founded in 1976 and has its headquarters in Tokyo, Japan. The company is divided into various divisions to offer a wide range of products to its customers. These divisions include health products, medical devices, clinical studies, and distribution. The health products division is one of the most comprehensive at Nihon Chouzai. The company offers an extensive selection of pharmaceuticals, dietary supplements, and health products. This also includes products for cosmetic purposes such as skincare products and sunscreen. Another important aspect of the health products division is customer education and consultation. Nihon Chouzai works closely with doctors and pharmacists to provide them with the best care and advice possible. The medical devices division focuses on the sale of devices used in medical practice. The product range includes diagnostic devices, patient treatment instruments, and medical imaging products. In this sector as well, Nihon Chouzai offers comprehensive consultation and training for doctors and medical personnel. Another important area for Nihon Chouzai is the conduct of clinical studies. The company offers its customers a comprehensive range of services and support in conducting clinical studies. This includes planning, implementation, monitoring, and reporting on clinical studies. In the distribution sector, Nihon Chouzai works closely with pharmaceutical manufacturers to market their products. Distribution is mainly done through pharmacies and medical facilities. Here, the company is strongly focused on customer retention and care, working closely with doctors and pharmacists to provide their customers with the best advice and care possible. Overall, Nihon Chouzai's business model is focused on the health and medical sectors. The company is dedicated to the development and marketing of pharmaceuticals and medical products to improve the health and well-being of people. It works closely with doctors and medical personnel to provide the best possible care and advice. The company has earned a reputation for the quality of its products and services and is committed to providing its customers with innovative solutions and top-notch customer service.
odotettu liikevaihto Nihon Chouzai Co on 383,90 Mrd. JPY. Tämä luku perustuu nykyisiin talousarvoihin ja heijastaa yhtiön liiketoimintasuoritusta.
odotettu voitto Nihon Chouzai Co on 4,30 Mrd. JPY. Nettovoitto kuvastaa yhtiön kannattavuutta kaikkien kulujen vähentämisen jälkeen.
Nihon Chouzai Co:n hinta-voitto-suhde (P/E) on tällä hetkellä 27,21. P/E-suhde vertaa nykyistä osakekurssia osakekohtaiseen tulokseen ja auttaa sijoittajia arvioimaan Nihon Chouzai Co-osakkeen arvostusta.
Nihon Chouzai Co:n hinta-myynti-suhde (P/S) on tällä hetkellä 0,30. P/S-suhde vertaa markkina-arvoa vuosittaisiin tuloihin ja toimii Nihon Chouzai Co-osakkeen arvostuskennuslukuna.
Nihon Chouzai Co:n Eulpool-laatuscore on 4/10.
Nihon Chouzai Co:n ISIN on JP3729200000. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.
Nihon Chouzai Co:n WKN on A0B8SZ. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.
Nihon Chouzai Co:n ticker on 3341.T. Tämä pörssinoteeraus käytetään Nihon Chouzai Co-osakkeiden kauppaan pörssissä.
Nihon Chouzai Co osake
Nihon Chouzai Co vertaisryhmä
Nihon Chouzai Co Ticker
Nihon Chouzai Co FIGI
Kaikki tunnusluvut ja syvällinen analyysi Nihon Chouzai Co:sta
Meidän osakeanalyysimme Nihon Chouzai Co-osakkeesta sisältää tärkeitä taloudellisia tunnuslukuja, kuten liikevaihdon, voiton, P/E-luvun, P/S-luvun, EBIT:n sekä tietoja osingosta. Lisäksi tarkastelemme asioita kuten osakkeet, markkina-arvo, velat, oma pääoma ja vastuut Nihon Chouzai Co:n yhteydessä. Jos etsit yksityiskohtaisempaa tietoa näistä aiheista, tarjoamme alisivuillamme kattavia analyysejä: